Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

163.30 -2.02 (-1.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corp

< Previous 1 2 3 Next >
$273M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Masimo's Skyrocketing Growth: Analyst Boosts Price Target Amid Exciting New Ventures
 
Via Benzinga
Masimo: Q1 Earnings Insights
 
Via Benzinga
A Preview Of Masimo's Earnings
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Shockwave Medical Stock With Rising Relative Strength
On Tuesday, Shockwave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 67 to 75. 
Via Investor's Business Daily
$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO's Employment Agreement
 
Via Benzinga
Expert Ratings for Masimo
 
Via Benzinga
The Latest Analyst Ratings for Masimo
 
Via Benzinga
Masimo's Return On Capital Employed Overview
 
Via Benzinga
Expert Ratings for Masimo
 
Via Benzinga
Analyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades Rating
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
 
Via Benzinga
Thoughts For Thursday: Risk-off, Risk-on
The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible. 
Via Talk Markets
NeurAxis: Should You Buy This IPO?
As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype. 
Via Talk Markets
7 Analysts Have This to Say About Masimo
 
Via Benzinga
6 Analysts Have This to Say About Masimo
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings: 
Via Benzinga
2 Under-the-Radar Medtech Stocks to Buy Now
Don't count out these discounted medical technology stocks. 
Via The Motley Fool
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier. 
Via Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better. 
Via Investor's Business Daily
How Masimo Is Taking On Electronics Giant Apple — And Winning
Apple could be on the hook for a royalty tied to its Apple Watch. 
Via Investor's Business Daily
Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
 
Via Benzinga
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Where Masimo Stands With Analysts
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
 
Via Benzinga
Over $17 Million Bet On Element Solutions? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
Masimo's Earnings Outlook
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Accenture Price Target Cut By This Analyst, Plus Deutsche Bank Predicts $483 For FactSet Research
Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.